JP Morgan Chase
ANIX icon

JP Morgan Chase’s Anixa Biosciences ANIX Stock Holding History

JP Morgan Chase’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,857
Closed -$26.6K – 7378
2023
Q4 		$26.6K Sell
6,857
-20,432
-75% -$68.9K ﹤0.01% 6182
2023
Q3 		$89.2K Hold
27,289
– – ﹤0.01% 5549
2023
Q2 		$87.3K Buy
27,289
+21,639
+383% +$83.4K ﹤0.01% 5522
2023
Q1 		$24.5K Buy
5,650
+5,000
+769% +$21.9K ﹤0.01% 5935
2022
Q4 		$3K Hold
650
– – ﹤0.01% 6236
2022
Q3 		$3K Hold
650
– – ﹤0.01% 6171
2022
Q2 		$2K Hold
650
– – ﹤0.01% 6271
2022
Q1 		$2K Hold
650
– – ﹤0.01% 6407
2021
Q4 		$2K Hold
650
– – ﹤0.01% 6493
2021
Q3 		$3K Hold
650
– – ﹤0.01% 6282
2021
Q2 		$3K Hold
650
– – ﹤0.01% 6170
2021
Q1 		$3K Sell
650
-296
-31% -$1.41K ﹤0.01% 5898
2020
Q4 		$3K Sell
946
-12
-1% -$30 ﹤0.01% 5483
2020
Q3 		$2K Hold
958
– – ﹤0.01% 5374
2020
Q2 		$3K Sell
958
-588
-38% -$1.22K ﹤0.01% 5226
2020
Q1 		$2K Hold
1,546
– – ﹤0.01% 5176
2019
Q4 		$5K Sell
1,546
-35,170
-96% -$129K ﹤0.01% 5464
2019
Q3 		$147K Buy
36,716
+28,280
+335% +$118K ﹤0.01% 4756
2019
Q2 		$29K Buy
8,436
+5,590
+196% +$23.6K ﹤0.01% 5363
2019
Q1 		$13K Buy
2,846
+1,300
+84% +$6.2K ﹤0.01% 5490
2018
Q4 		$6K Sell
1,546
-1,692
-52% -$7.27K ﹤0.01% 5508
2018
Q3 		$15K Buy
3,238
+2,342
+261% +$8.82K ﹤0.01% 5454
2018
Q2 		$3K Hold
896
– – ﹤0.01% 5451
2018
Q1 		$3K Hold
896
– – ﹤0.01% 5262
2017
Q4 		$2K Hold
896
– – ﹤0.01% 5364
2017
Q3 		$3K Hold
896
– – ﹤0.01% 4839
2017
Q2 		$1K Buy
+896
New +$1.24K ﹤0.01% 4872

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $4.86B AUM 22.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's ANIX Position: Q1 2024 in Review

JP Morgan Chase sold out of Anixa Biosciences (ANIX) in Q1 2024, closing a stake of 6,857 shares — an estimated $26.6K sold.

JP Morgan Chase first reported a position in ANIX in Q2 2017 and held it in 27 quarters. The position peaked at $147K in Q3 2019. 58 funds tracked by Wall St. Rank hold ANIX as of Q1 2024.

  • JP Morgan Chase reported no remaining Anixa Biosciences position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 6,857 Anixa Biosciences shares in Q1 2024, an estimated $26.6K.
  • JP Morgan Chase first reported a position in Anixa Biosciences in Q2 2017 and held it in 27 quarters.
  • JP Morgan Chase's Anixa Biosciences position peaked at $147K in Q3 2019.
  • 58 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.